All lobbying filings
EAST END GROUP, LLC
EAST END GROUP, LLC filed a Q3 termination report for ALVOGEN on July 15, 2026, reporting no lobbying activity.
Lobbying for ALVOGEN · Pharmaceutical company developing and manufacturing generic, brand and biosimilar products
Filing · LD-2 quarterly report
Q3 terminationNo activity
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Jul 15, 2026
Income
$45,000
What the client paid this registrant for the period.
Client based in
New Jersey
Representation ended
Jul 1, 2026
The registrant reported terminating its work for this client.
Lobbying activity
0
No itemized activity in this filing.